Recurrence patterns and risk factors following thoracoscopic esophagectomy with radical lymph node dissection for thoracic esophageal squamous cell carcinoma

Ninomiya,Itasu; Okamoto,Koichi; Tsukada,Tomoya; Kinoshita,Jun; Oyama,Katsunobu; Fushida,Sachio; Osugi,Harushi; Ohta,Tetsuo

doi:10.3892/mco.2015.688

Recurrence patterns and risk factors following thoracoscopic esophagectomy with radical lymph node dissection for thoracic esophageal squamous cell carcinoma

Authors:
- Itasu Ninomiya
- Koichi Okamoto
- Tomoya Tsukada
- Jun Kinoshita
- Katsunobu Oyama
- Sachio Fushida
- Harushi Osugi
- Tetsuo Ohta
View Affiliations

Affiliations: Gastroenterologic Surgery, Department of Oncology, Division of Cancer Medicine, Graduate School of Medical Science, Kanazawa University, Kanazawa, Ishikawa 920‑8641, Japan, Department of Gastroenterological Surgery, Osaka City University, Graduate School of Medicine, Osaka 565‑0871, Japan
Published online on: November 25, 2015 https://doi.org/10.3892/mco.2015.688
Pages: 278-284

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to clarify the therapeutic effect of thoracoscopic esophagectomy with radical lymph node dissection based on the recurrence pattern, and identify the risk factors for relapse‑free survival in patients with esophageal cancer. The recurrence patterns in 140 patients who underwent complete thoracoscopic radical esophagectomy between January 2003 and December 2012 were investigated. The risk factors for recurrence were examined by univariate and multivariate analysis. Mediastinal recurrence in association with initial lymphatic metastasis was precisely analyzed. Esophageal cancer recurred in 49 (35.0%) of the 140 patients. The median recurrence time was 259 (45‑2,560) days after the initial treatment. The patterns of initial recurrence among the 140 patients included hematological recurrence in 24 patients (17.1%), lymphatic recurrence in 26 (18.6%), pleural dissemination in 5 (3.6%), peritoneal dissemination in 2 (1.4%), and local recurrence in 4 (2.9%). Lymphatic recurrence within the mediastinal regional lymphatic stations occurred in only 8 (5.7%) of the 140 patients. Univariate analysis for relapse‑free survival showed that the statistically significant variables were a tumor location in the upper third of the esophagus, stage of pT3 or pT4, presence of nodal metastasis, pStage of III or IV, presence of a residual tumor, performance of preoperative chemotherapy and performance of postoperative therapy. Multivariate analysis showed that only nodal metastasis and a positive residual tumor were statistically significant independent risk factors for relapse‑free survival. Lymphatic recurrence within the mediastinum, particularly the station around the bilateral recurrent laryngeal nerves, was infrequent and independent of the initial metastatic distribution. Thoracoscopic esophagectomy with radical lymph node dissection provides favorable locoregional control. Lymphatic recurrence within the mediastinal regional nodes is infrequent and independent of the initial lymph node metastasis. A pathological residual tumor and lymph node metastasis are significant risk factors for recurrence.

View Figures

View References

1	Akiyama H, Tsurumaru M, Udagawa H and Kajiyama Y: Radical lymph node dissection for cancer of the thoracic esophagus. Ann Surg. 220:364–372. 1994. View Article : Google Scholar : PubMed/NCBI
2	Fujita H, Kakegawa T, Yamana H, Shima I, Toh Y, Tomita Y, Fujii T, Yamasaki K, Higaki K and Noake T: Mortality and morbidity rates, postoperative course, quality of life and prognosis after extended radical lymphadenectomy for esophageal cancer. Comparison of three-field lymphadenectomy with two-field lymphadenectomy. Ann Surg. 222:654–662. 1995. View Article : Google Scholar : PubMed/NCBI
3	Udagawa H, Ueno M, Shinohara H, Haruta S, Kaida S, Nakagawa M and Tsurumaru M: The importance of grouping of lymph node stations and rationale of three-field lymphoadenectomy for thoracic esophageal cancer. J Surg Oncol. 106:742–747. 2012. View Article : Google Scholar : PubMed/NCBI
4	Bhansali MS, Fujita H, Kakegawa T, Yamana H, Ono T, Hikita S, Toh Y, Fujii T, Tou U and Shirouzu K: Pattern of recurrence after extended radical esophagectomy with three-field lymph node dissection for squamous cell carcinoma in the thoracic esophagus. World J Surg. 21:275–281. 1997. View Article : Google Scholar : PubMed/NCBI
5	Mariette C, Balon JM, Piessen G, Fabre S, Van Seuningen I and Triboulet JP: Pattern of recurrence following complete resection of esophageal carcinoma and factors predictive of recurrent disease. Cancer. 97:1616–1623. 2003. View Article : Google Scholar : PubMed/NCBI
6	Nakagawa S, Kanda T, Kosugi S, Ohashi M, Suzuki T and Hatakeyama K: Recurrence pattern of squamous cell carcinoma of the thoracic esophagus after extended radical esophagectomy with three-field lymphadenectomy. J Am Coll Surg. 198:205–211. 2004. View Article : Google Scholar : PubMed/NCBI
7	Miyata H, Yamasaki M, Kurokawa Y, Takiguchi S, Nakajima K, Fujiwara Y, Konishi K, Mori M and Doki Y: Survival factors in patients with recurrence after curative resection of esophageal squamous cell carcinomas. Ann Surg Oncol. 18:3353–3361. 2011. View Article : Google Scholar : PubMed/NCBI
8	Osugi H, Takemura M, Takada N, Hirohashi K, Kinoshita H and Higashino M: Prognostic factors after oesophagectomy and extended lymphadenectomy for squamous oesophageal cancer. Br J Surg. 89:909–913. 2002. View Article : Google Scholar : PubMed/NCBI
9	Shimada H, Okazumi S, Matsubara H, Nabeya Y, Shiratori T, Shimizu T, Shuto K, Hayashi H and Ochiai T: Impact of the number and extent of positive lymph nodes in 200 patients with thoracic esophageal squamous cell carcinoma after three-field lymph node dissection. World J Surg. 30:1441–1449. 2006. View Article : Google Scholar : PubMed/NCBI
10	Cuschieri A, Shimi S and Banting S: Endoscopic oesophagectomy through a right thoracoscopic approach. J R Coll Surg Edinb. 37:7–11. 1992.PubMed/NCBI
11	Nagpal K, Ahmed K, Vats A, Yakoub D, James D, Ashrafian H, Darzi A, Moorthy K and Athanasiou T: Is minimally invasive surgery beneficial in the management of esophageal cancer? A meta-analysis. Surg Endosc. 24:1621–1629. 2010. View Article : Google Scholar : PubMed/NCBI
12	Biere SS, van Berge Henegouwen MI, Maas KW, Bonavina L, Rosman C, Garcia JR, Gisbertz SS, Klinkenbijl JH, Hollmann MW, de Lange ES, et al: Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: A multicentre, open-label, randomised controlled trial. Lancet. 379:1887–1892. 2012. View Article : Google Scholar : PubMed/NCBI
13	Osugi H, Takemura M, Higashino M, Takada N, Lee S and Kinoshita H: A comparison of video-assisted thoracoscopic oesophagectomy and radical lymph node dissection for squamous cell cancer of the oesophagus with open operation. Br J Surg. 90:108–113. 2003. View Article : Google Scholar : PubMed/NCBI
14	Thomson IG, Smithers BM, Gotley DC, Martin I, Thomas JM, O'Rourke P and Barbour AP: Thoracoscopic-assisted esophagectomy for esophageal cancer: Analysis of patterns and prognostic factors for recurrence. Ann Surg. 252:281–291. 2010. View Article : Google Scholar : PubMed/NCBI
15	Kinjo Y, Kurita N, Nakamura F, Okabe H, Tanaka E, Kataoka Y, Itami A, Sakai Y and Fukuhara S: Effectiveness of combined thoracoscopic-laparoscopic esophagectomy: Comparison of postoperative complications and midterm oncological outcomes in patients with esophageal cancer. Surg Endosc. 26:381–390. 2012. View Article : Google Scholar : PubMed/NCBI
16	Ninomiya I, Osugi H, Fujimura T, Kayahara M, Takamura H, Takemura M, Lee S, Nakagawara H, Nishimura G and Ohta T: Results of video-assisted thoracoscopic surgery for esophageal cancer during the induction period. Gen Thorac Cardiovasc Surg. 56:119–125. 2008. View Article : Google Scholar : PubMed/NCBI
17	Ninomiya I, Okamoto K, Fujimura T, Fushida S, Osugi H and Ohta T: Oncologic outcomes of thoracoscopic esophagectomy with extended lymph node dissection: 10-year experience from a single center. World J Surg. 38:120–130. 2014. View Article : Google Scholar : PubMed/NCBI
18	Sobin LH, Gospodarowicz MK and Wittekind C: TNM classification of malignant tumors (7th). Oxford: Wiley-Blackwell. 2010.
19	Japanese Esophageal Society: Japanese Classification of Esophageal Cancer, Tenth Edition: Part I. Esophagus. 6:1–25. 2009. View Article : Google Scholar
20	Japanese Esophageal Society: Japanese Classification of Esophageal Cancer, Tenth edition: Parts II and III. Esophagus. 6:71–94. 2009. View Article : Google Scholar
21	Ando N, Kato H, Igaki H, Shinoda M, Ozawa S, Shimizu H, Nakamura T, Yabusaki H, Aoyama N, Kurita A, et al: A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907). Ann Surg Oncol. 19:68–74. 2012. View Article : Google Scholar : PubMed/NCBI
22	Smit JK, Guler S, Beukema JC, Mul VE, Burgerhof JG, Hospers GA and Plukker JT: Different recurrence pattern after neoadjuvant chemoradiotherapy compared to surgery alone in esophageal cancer patients. Ann Surg Oncol. 20:4008–4015. 2013. View Article : Google Scholar : PubMed/NCBI
23	Ozawa S, Ito E, Kazuno A, Chino O, Nakui M, Yamamoto S, Shimada H and Makuuchi H: Thoracoscopic esophagectomy while in a prone position for esophageal cancer: A preceding anterior approach method. Surg Endosc. 27:40–47. 2013. View Article : Google Scholar : PubMed/NCBI